MEXC and Payward Signal Intent to Explore Broader | Crypto News
Mutsamudu, Comoros, October 5, 2026, MEXC, a pioneer in 0-fee digital asset trading, and Payward, the mother or father company of Kraken, are in discussions to explore a collaboration as both platforms look at how exchanges can better serve customers across evolving global markets. The two firms will convey the dialog to TOKEN2049 Singapore, where MEXC CEO Vugar Usi Zade and Payward Co-CEO Arjun Sethi will be part of a panel on the MEXC Stage to focus on the next part of trading platforms and share additional views on collaboration between exchanges.
The dialogue comes as trading platforms reply to a number of shifts taking place at the same time. Users are searching for broader access across crypto and conventional markets, AI is altering how buyers research and work together with trading instruments, and social trading is creating new methods to uncover and take part in market alternatives. Against this backdrop, exchanges are more and more trying past particular person merchandise toward how market access, infrastructure, liquidity and consumer expertise can work together more successfully. As platforms evolve, exchange security and consumer asset safety will also stay an important half of the dialog.
As the exchange industry evolves, platforms are building different strengths across consumer expertise, market access, infrastructure and trading capabilities. MEXC has centered on retail consumer expertise, deep liquidity and perpetual trading across crypto and TradFi property, while Payward brings global compliant financial infrastructure, skilled trading capabilities and a strong U.S. market presence. These different strengths create room to explore where broader collaboration might add worth for customers.
“Users increasingly expect broader market access without more complexity,” said Vugar Usi Zade, CEO of MEXC. “The next stage of trading will require strong user experience, liquidity, infrastructure and market access to work more closely together. As exchanges continue to evolve, there is growing room to explore where collaboration across the industry can create more value for users.”
The TOKEN2049 panel will happen on October 7 from 12:30 to 13:00 at the MEXC Stage, and will explore the trends reshaping trading, how exchanges are getting ready for altering consumer expectations, and where higher collaboration between platforms might create worth. The dialog will also look at the convergence of crypto and TradFi, the growing position of AI in trading, and how global trading platforms might evolve as markets and infrastructure grow to be more linked.
About MEXC
Founded in 2018, MEXC is a main global multi-asset trading platform constructed as your 0-fee gateway to infinite alternatives. Serving customers across 170+ markets, MEXC supplies simple and environment friendly access to crypto, shares, tokenized property, derivatives, and a growing vary of TradFi-linked alternatives through one account and one gateway.
With 0 trading charges, deep liquidity, broad asset coverage, and a high-performance trading expertise, MEXC is designed for retail customers who need to uncover earlier, act quicker, and commerce with fewer limitations. As crypto and conventional finance continue to converge, MEXC is dedicated to making global alternatives more accessible, serving to customers commerce freely and MEXCmize every alternative.
MEXC Official Website｜ X ｜ Telegram ｜How to Sign Up on MEXC
For media inquiries, please contact MEXC PR staff: media@mexc.com
Risk Disclaimer:
This content doesn’t represent investment advice. Given the volatility of financial markets, including digital property, tokenized property, and conventional financial merchandise, buyers ought to rigorously assess market situations, underlying asset fundamentals, and potential financial dangers before making any investment or trading selections.
Stay up to date with the latest trending crypto news! Visit our web site daily for the freshest Crypto news and content, rigorously curated to keep you informed.
